Recently, foreign pharmaceutical makers such as AbbVie, AstraZeneca, Novartis, Sanofi, and Roche slashed the prices of a large number of drugs sold in China, the world’s second largest drug market. They cut prices far below their prices in the United States (US) and elsewhere so Beijing would put these drugs...
